Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Sinopharm Group Co Ltd (1099)

Hong Kong
Currency in HKD
Disclaimer
19.62
+0.20(+1.03%)
Closed

1099 Comments

UBS Lowers SINOPHARM TP to $28, Rated Buy
In the end Sinopharm is the only one ripping higher in this bad period for stocks. Better you refer to your TA, foundamental analysis is not your game.
*Citi Cuts SINOPHARM TP to $26, Rated Buy
M Stanley Trims SINOPHARM TP to $20.6, Rated Equalweight
C Suisse Trims SINOPHARM TP to $26; Rated Outperform
M Stanley Trims SINOPHARM TP to $30.6, Rated Overweight
Hi im trying to buy shares on HK market in saxo. It says that I need to buy 400 shares of sinopharm. is this a saxo condition? thanks
yes。
Minimum 400
Not only Saxo, 1 Lot=400 Shares
M Stanley Raises SINOPHARM TP to $31; Rated *Overweight*
I've realized I'm fine with 3.57% dividend on this stock, and i hope it could go not go much more down
Hold almost 3 month always decline price
Why it's not going above 20.. When the vaccine is approved from different countries?
Because Sinopharm HK is just a distributor of Sinopharm China's products, and the deals by those countries who approve to use the vaccine are between government to government level.
Then better sell
BEIJING: 2 COVID-19 vaccines from Sinopharm triggered immunity against a highly transmissible coronavirus variant first found in South Africa, but their effect appeared weaker, a small-sample lab study released on Tuesday (Feb 2) showed.
Pakistan approves Chinese Sinopharm Covid -19 vaccine for em ..Read more at:http://m.timesofindia.com/articleshow/80340241.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Cambodia (CGTN Jan, 17) - Cambodia's Prime Minister Hun Sen said on Sunday that he will be the first in the country to be inoculated with a COVID-19 vaccine developed by China's Sinopharm to boost the public's confidence in the shot.On Friday night, Hun Sen announced that he had accepted a donation of 1 million doses of the Sinopharm vaccine.He said apart from the donation, the government will continue to seek more vaccine doses for 10 million or up to 13 million people if there is a need to vaccinate up to 80 percent of the country's population.
Serbia receives million doses of China's Sinopharm COVID-19 vaccine.BELGRADE (Reuters Jan, 16) - A plane carrying one million doses of Sinopharm’s COVID-19 vaccine arrived on Saturday in Serbia, making it the first European country to receive the Chinese vaccine for mass inoculation programmes.Slideshow ( 5 images )President Aleksandar Vucic was accompanied by Beijing’s ambassador to the Balkan country at Belgrade’s airport as containers carrying the vaccines were unloaded from an Air Serbia plane.“I would like to thank President Xi Jinping and Chinese leadership for sending us one million doses of the vaccine,” Vucic, who has helped forge close ties with China in recent years, told reporters.
Hi George, as a Serbian I bought some of these stocks. Do you think this stock is good to be held for a long time?
May be not as all their vaccine dealings so far are between government to government. So that has not benefited their listed entity in HK stock exchange.
Sinopharm arrived in Europe  https://www.reuters.com/article/us-health-coronavirus-vaccines-hungary/hungary-reaches-deal-to-buy-chinas-sinopharm-vaccine-pm-aide-says-idUSKBN29J13A
DAKAR (Reuters) Jan 13 - Senegal is in talks to buy at least 200,000 doses of a coronavirus vaccine developed by China's Sinopharm, Health Minister Abdoulaye Diouf Sarr said on Wednesday.Senegal this month said it would buy extra vaccines to complement those it will get through the World Health Organization-backed COVAX scheme, which aims to deliver 1.3 billion doses this year to 92 low- and middle-income nations.
AFP (Jan 9) - Jordan said on Saturday it has approved China's Sinopharm coronavirus vaccine for emergency use. "Emergency use of the... Sinopharm vaccine against the novel coronavirus has been authorised," the head of the Jordanian Food and Drug administration, Nizar Mheidat, told state television.
Egypt’s Minister of Health has announced legislative approval for the emergency use of the Chinese Sinopharm coronavirus vaccine.Hala Zayed said: “We have obtained the approval of the Egyptian Drug Authority (EDA) for an emergency license to use the Sinopharm vaccine.”She indicated that the vaccine would start to be distributed to medical staff in the second week of January.
NAIROBI, Kenya -- The Indian Ocean island nation of the Seychelles says it will begin administering COVID-19 vaccinations on Sunday with the 50,000 doses it has of the Chinese-developed Sinopharm vaccine.Health Minister Peggy Vidot told reporters on Thursday that political leaders will be first to be vaccinated, then health workers, the Seychelles News Agency reported. President Wavel Ramkalawan has said he will be the first to get the vaccine.
LIMA, Jan. 6 (Xinhua) -- Peru has signed an agreement with Chinese pharmaceutical firm Sinopharm to acquire its vaccine against COVID-19, with the first 1 million doses to arrive this month, Peruvian President Francisco Sagasti announced Wednesday.
Global Times published on Dec 24, 2020: Chinese drug regulators formally accepted the country's leading vaccine producer Sinopharm's application for market rollout of its COVID-19 vaccines on Wednesday, which marks a closer step to China's approval for this vaccine candidate to combat the coronavirus.The Center for Drug Evaluation of China's National Medical Products Administration has formally accepted the application and started examination procedure, the Global Times learned from the Sinopharm.Chinese experts predicted that conditional approval could be granted from January 1, 2021. Shares of Sinopharm jumped 9 percent following the news. Shares linked to cold chain transport for vaccines also saw gains.
this time next year we'll be millionaires ;-) STRONG BUY !!! https://www.nature.com/articles/d41586-020-03563-z
https://www.bolsamania.com/capitalbolsa/noticias/social/la-vacuna-china-covid-19-podria-estar-lista-para-fines-de-2020-sinopharm--7583709.html
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.